Activated PD-1+ CD4 T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
暂无分享,去创建一个
J. Baeten | M. McElrath | E. Sanders-Buell | M. Robb | N. Michael | E. Katabira | M. Eller | B. Slike | S. Tovanabutra | M. Nau | Matthew Creegan | D. Bolton | S. Ratto-Kim | S. Krebs | T. Hong | J. Sandberg | M. Creegan
[1] R. Siliciano,et al. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir , 2018, Retrovirology.
[2] R. Siliciano,et al. Transcriptional Reprogramming during Effector‐to‐Memory Transition Renders CD4+ T Cells Permissive for Latent HIV‐1 Infection , 2017, Immunity.
[3] J. Mellors,et al. Future technologies for monitoring HIV drug resistance and cure , 2017, Current opinion in HIV and AIDS.
[4] Todd M. Allen,et al. The epigenetic landscape of T cell exhaustion , 2016, Science.
[5] O. Lund,et al. CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection , 2016, AIDS.
[6] S. Lewin,et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART , 2016, PLoS pathogens.
[7] Jeffrey N. Martin,et al. Immunologic profiles distinguish aviremic HIV-infected adults , 2016, AIDS.
[8] O. Lund,et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection , 2015, PloS one.
[9] M. Merad,et al. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells , 2014, Nature Communications.
[10] M. Lederman,et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. , 2014, The Journal of infectious diseases.
[11] M. Lederman,et al. HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality , 2014, PLoS pathogens.
[12] O. Lund,et al. Multiparametric Bioinformatics Distinguish the CD4/CD8 Ratio as a Suitable Laboratory Predictor of Combined T Cell Pathogenesis in HIV Infection , 2014, The Journal of Immunology.
[13] Jeffrey N. Martin,et al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. , 2013, The Journal of infectious diseases.
[14] M. Lederman,et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. , 2011, The Journal of infectious diseases.
[15] N. Sewankambo,et al. Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans , 2011, PloS one.
[16] M. Robb,et al. Quality Monitoring of HIV-1-Infected and Uninfected Peripheral Blood Mononuclear Cell Samples in a Resource-Limited Setting , 2010, Clinical and Vaccine Immunology.
[17] Mario Roederer,et al. Immunologic and virologic events in early HIV infection predict subsequent rate of progression. , 2010, The Journal of infectious diseases.
[18] Geneviève Boucher,et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.
[19] A. Esposito,et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART , 2006, AIDS.
[20] N. Jones,et al. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. , 2005, The Journal of infectious diseases.
[21] Peter Hunt,et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.
[22] Jeffrey N. Martin,et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.
[23] J. Baeten,et al. Use of hormonal contraceptives and risk of HIV-1 transmission : a prospective cohort study , 2011 .
[24] S. Gichuhi. Partners In Prevention Hsv/hiv Transmission Study Team , 2010 .